Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- Income Deprivation Over Time, Moving in Childhood, and Adult Risk of Depression September 1, 2024This cohort study comprising more than 1 million individuals evaluates whether changing neighborhood income deprivation and residential moves during childhood are associated with the risk of depression in adulthood.
- Transmission of Mental Disorders in Adolescent Peer Networks September 1, 2024This cohort study examines the transmission of mental disorders among adolescents observed in follow-up after school exposure to 1 or more classmates diagnosed with a mental disorder.
- Trajectories of Inflammation in Youth and Risk of Mental and Cardiometabolic Disorders in Adulthood August 21, 2024This longitudinal cohort study using data from the Avon Longitudinal Study of Parents and Children (ALSPAC) examines trajectories of inflammation in childhood and their associations with mental and related cardiometabolic health outcomes in early adulthood.
- Semaglutide in Psychiatry August 21, 2024This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
- Inflammatory Biomarkers and Risk of Psychiatric Disorders August 21, 2024This cohort study investigates the association between inflammatory biomarkers and risk of psychiatric disorders.
JAMA Oncology Current Issue
- Lymphoma With a Skin Rash August 1, 2024A 62-year-old female had a generalized vesiculobullous rash on her face for 4 months. It started over the lips and gradually progressed to involve the oral mucosa and skin of the whole body. What is your diagnosis?
- Immunotherapy For US Patients With Metastatic Cancer at the End of Life—Reply August 1, 2024In Reply We agree with Higashi et al that studies including performance status, quality-of-life metrics, and specific immunotherapy agents used at the end of life would provide additional helpful insights into the trends reported in our study. We regret that these data are not available in the National Cancer Database. In regard to the comment […]
- Valid Analysis of Brain-Specific Progression-Free Survival August 1, 2024Chen and colleagues conducted a clinical trial to investigate whether the addition of an induction treatment of bevacizumab, etoposide, and cisplatin (BEEP) would improve brain-specific progression-free survival (PFS) after whole-brain radiotherapy. The primary end point was brain PFS as assessed by local investigators. The study was designed to detect a hazard ratio of 0.6 with […]
- Valid Analysis of Brain-Specific Progression-Free Survival—Reply August 1, 2024In Reply We appreciate Armbruster et al and Yu et al for their interest and comments regarding our A-PLUS study.
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.
Recent Activities
RMEI CE Featured Activities
1.0 CE Credit(s)